Ergoteles’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-48,494
Closed -$431K 1350
2023
Q1
$431K Buy
+48,494
New +$431K 0.02% 787